Compare BMRN & CLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | CLX |
|---|---|---|
| Founded | 1996 | 1913 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 13.0B |
| IPO Year | 1999 | 1994 |
| Metric | BMRN | CLX |
|---|---|---|
| Price | $64.61 | $89.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 12 |
| Target Price | $88.22 | ★ $110.25 |
| AVG Volume (30 Days) | 1.9M | ★ 2.7M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 5.23% |
| EPS Growth | N/A | ★ 189.78 |
| EPS | 0.77 | ★ 3.47 |
| Revenue | $1,313,646,000.00 | ★ $6,124,000,000.00 |
| Revenue This Year | $15.02 | N/A |
| Revenue Next Year | $12.23 | $8.64 |
| P/E Ratio | $83.94 | ★ $26.40 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $84.70 |
| 52 Week High | $70.98 | $128.90 |
| Indicator | BMRN | CLX |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 26.52 |
| Support Level | $64.07 | $89.20 |
| Resistance Level | $66.28 | $99.81 |
| Average True Range (ATR) | 1.59 | 2.61 |
| MACD | -0.42 | -1.81 |
| Stochastic Oscillator | 21.14 | 3.85 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Since its inception more than 100 years ago, Clorox has expanded to operate in an array of consumer product categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Nearly 85% of Clorox's sales come from its home turf.